Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SHS International
Liverpool, United Kingdom
- Ownership
- Private
- Development stage
- Other
01
Overview
SHS International, founded in 1960, pioneered phenylalanine-free products for PKU and developed the first amino acid-based infant formulas; notable products include Neocate, XP Analog, and Maxamaid. The company’s products are approved for use in infants (Neocate received FDA approval for infants up to one year in 1995) and encompass a full range of metabolic and allergy-focused medical nutrition.
- Therapeutic areas
- ImmunologyNephrologyMetabolic DisordersGastroenterologyNeurology
- Modalities
- Medical foodDietary products
- Industry
- Food & Nutrition
02
Partnerships
None explicitly listed in sources; collaborates within Danone/Nutricia network
Beyond the preview
Go deeper on SHS International.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SHS International.